Related Experiment Video
Updated: Jul 13, 2026

Modeling Ascending Vaginal Infection, Preterm Birth, and Neonatal Morbidity in Mice
Published on: October 10, 2025
Is it time to revisit routine administration of antibiotic for preterm prelabor rupture of membranes?
1St George's Hospital, Blackshaw Road, London SW17 0QT, UK. augwumad@sgul.ac.uk.
Insights
Antibiotic therapy for preterm prelabor rupture of membranes (pPROM) may not eradicate intra-amniotic infection. Further research is needed to understand the impact of antibiotics on intrauterine infection and inflammation in pPROM cases.
Area of Science:
- Obstetrics and Gynecology
- Neonatal Medicine
- Infectious Diseases
Background:
- Preterm prelabor rupture of membranes (pPROM) is a major cause of preterm birth, increasing risks for neonatal morbidity and mortality.
- Intrauterine infection/inflammation is a significant factor in pPROM, but its natural history and the effects of antibiotic treatment remain poorly understood.
- Broad-spectrum antibiotics are standard care for pPROM, based on evidence suggesting they delay delivery and reduce complications, despite limited understanding of their impact on intra-amniotic infection.
Discussion:
- This article critically examines a study investigating whether maternal antibiotic administration effectively eliminates intra-amniotic infection and inflammation in cases of pPROM.
- The study's findings are evaluated in the context of current clinical practices and the known risks associated with intrauterine infection/inflammation.
- The limited scope of the study necessitates careful interpretation of its results regarding the efficacy of antibiotics in treating intra-amniotic infections.
Key Insights:
- The study suggests that antibiotic administration in pPROM may not consistently eradicate intra-amniotic infection or inflammation.
- Understanding the precise mechanisms by which antibiotics affect intrauterine infections is crucial for optimizing treatment protocols.
- The findings challenge the assumption that current antibiotic regimens fully address the infectious component of pPROM.
Outlook:
- Further large-scale, rigorous studies are required to confirm these findings and elucidate the role of antibiotics in managing intra-amniotic infection/inflammation in pPROM.
- Future research should focus on targeted antibiotic therapies and non-antibiotic interventions to manage intrauterine infections.
- Clarifying the impact of antibiotics on intra-amniotic environments is essential for improving outcomes for preterm infants born after pPROM.
Abstract:
Preterm prelabor rupture of membranes (pPROM) is the precursor of up to 40% of preterm deliveries and an independent risk factor for neonatal disease, death and long-term pulmonary and neurodevelopmental deficits. A significant proportion of cases of pPROM are infection driven, although these are difficult to delineate in clinical practice. Our understanding of the natural history of intrauterine infection/inflammation is rudimentary at best. Even less is our knowledge of the influence of antibiotic therapy on the course of intrauterine infection. Yet, evidence that suggested that antibiotic therapy for pPROM delayed preterm delivery and reduced maternal and neonatal morbidity was adopted, and routine administration of broad-spectrum antibiotic is now part of the standard of care for patients with pPROM. This article evaluates the findings of a recent small but, in my opinion, very important study that aimed to determine whether antibiotic administration to the mother eradicated intra-amniotic infection and/or inflammation, both recognized potent risk factors for preterm delivery and adverse neonatal/childhood outcomes.
More Related Videos
07:36Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
08:50A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development
Published on: June 24, 2020
Related Concept Videos
Microbiota Modulation by Antibiotics
Development of the Oral Microbiota
Acute Pyelonephritis II: Diagnostic Studies and Management
Pharmacokinetics in Pediatric Patients: Drug Excretion
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Dosage Interval and Administration Route: Determination Methods